Click on the titles to access the content
IMSN CVSIG Charter
- IMSN Covid-19 Vaccine Safety Interest Group Charter Read on…
IMSN CVSIG List of participants
Country | Organization | Contact |
Brazil | Instituto para Práticas Seguras no Uso de Medicamentos (ISMP-Brasil) | Mario Borges |
Canada | Institute for Safe Medication Practices Canada (ISMP-Canada) | David U (temporary) |
Canada | Institute for Safe Medication Practices Canada (ISMP-Canada) | Dorothy Tscheng |
Canada | Health Canada | Sally Pepper |
Canada | Health Canada | Jhona Rose |
Colombia | Colombian Society of Hospital Pharmacists (ACQFH) | Ismael Basto |
Colombia | Colombian Society of Hospital Pharmacists (ACQFH) | Juan Pablo Osorio |
European Union | European Medicines Agency (EMA) | Alexios Skarlatos |
France | French Network of Pharmacovigilance Centers | Marie-Blanche Rabier |
France | Prescrire' Preventing the Preventable Programme | Etienne Schmitt |
Germany | Head of the Hospital Pharmacy of Heidelberg University Hospital | Torsten Hoppe-Tichy |
Germany | Drug Commission of the German Medical Association (AkdÄ) | Birgit Vogt |
Hong Kong | Hospital Authority Chief Pharmacist | Benjamin Lee |
Ireland | Health Service Executive | Muriel Pate |
Ireland | Irish Medication Safety Network | Niamh O’Hanlon |
ISOP | Chair of the ISOP Medication Errors Group | Brian Edwards |
ISOP | Co-Chair of the ISOP Medication Errors Group | Angela Cora |
Morocco | Morocco Poison Control and Pharmacovigilance Centre (CAPM) | Ghita Benabdallah |
Morocco | Morocco Poison Control and Pharmacovigilance Centre (CAPM) | Houda Sefiani |
Netherlands | Instituut Verantwoord Medicijngebruik - Voorkomen Medicatie-Incidenten (VMI) | Jaap Dik |
Netherlands | Instituut Verantwoord Medicijngebruik - Voorkomen Medicatie-Incidenten (VMI) | Rob Essink |
New Zealand | New Zealand Pharmacovigilance Centre | Michael Tatley |
Norway | Norway Medicine Agency | Sigurd Hortemo |
Saudi Arabia | Saudi Medication Safety Center | Hind Modaimegh |
Singapore | Chairperson of the National Medication Safety Committee | Augustine Tse |
Spain | Instituto para el Uso Seguro de los Medicamentos (ISMP-España) | Maria Jose Otero |
UAE | Emirates Pharmaceutical Society | Sohail Fitieh |
UK | Medicines and Healthcare products Regulatory Agency (MHRA) | Mitul Jadeja |
UK | National Health Service (NHS) | Jennie Hall |
UMC | Uppsala Monitoring Centre (UMC) | Alem Zekarias |
USA | Institute for Safe Medication Practices ISMP | Christina Michalek |
USA | Institute for Safe Medication Practices ISMP | Mike Cohen |
USA | Institute for Safe Medication Practices ISMP | Rita Jew |
USA | International Medication Safety Management Fellow | Jill Paslier |
USA | International Medication Safety Management Fellow | Merissa Andersen |
USA | US Food & Drug Administration FDA | Lubna Merchant |
USA | Vaccine Dynamics | John Grabenstein |
WHO | Pharmacovigilance (PVG), as observer | Ayako Fukishima |
February 11, 2021 CVSIG meeting
,
- Minutes,
taken by Jill Paslier, ISMP International Medication Safety Management Fellow - Chat transcript
March 11, 2021 CVSIG meeting
- Agenda
- Minutes,
taken by Jill Paslier, ISMP International Medication Safety Management Fellow - Chat transcript
- France approach to COVID-19 vaccinations – Marie-Blanche Valnet-Rabier Read on…
- Ireland approach to COVID-19 vaccinations – Niamh O’Hanlon Read on…
- US approach to COVID-19 vaccinations – Michael Cohen Read on…
April 8, 2021 CVSIG meeting
- Agenda
- Minutes,
taken by Jill Paslier, ISMP International Medication Safety Management Fellow - Chat transcript
- The Canadian experience – ISMP Canada and Health Canada; Sally Pepper Read on…
- The Norwegian experience – Sigurd Hortemo Read on…
- An update from Uppsala Monitoring Centre – Alem Zekarias Read on…
- CVSIG survey review by ISMP Fellows - Merissa Andersen and Jill Paslier Read on…
May 6, 2021 CVSIG meeting
June 3, 2021 CVSIG meeting
- Agenda
- Minutes,
taken by Jill Paslier, ISMP International Medication Safety Management Fellow - Comments on The Morocco experience – Dr. Ghita Benabdallah Read on…
- The Saudi Arabia experience – Dr. Hind Almodaimegh Read on…
- Covid-19 Vaccines International Nonproprietary Names (INN) - Dr Raffaella Balocco Mattavelli, World Health Organization. Oral presentation with reference to Loizides U, Adisa A, López de la Rica Manjavacas A, et al. WHO international non-proprietary names: the need to distinguish COVID-19 vaccines. Lancet 2021; 397 (10274): 577-578. Read on…
July 15, 2021 CVSIG meeting
- Agenda: development of a guidance document
- Minutes,
taken by Merissa Andersen, ISMP International Medication Safety Management Fellow